| Literature DB >> 36225140 |
Rodrigo A Aguayo-Romero1,2,3, Christopher M Cannon4, Andrea L Wirtz5, Erin E Cooney6, Kenneth H Mayer2,3,7, Sari L Reisner1,2,3,7.
Abstract
INTRODUCTION: Transgender women (TW) experience an increased risk of human immunodeficiency virus (HIV) acquisition. This study identified patterns of HIV awareness and prevention strategies used by TW who were not living with HIV.Entities:
Keywords: HIV prevention strategies; PEP; PrEP; gender diverse; latent class analysis; transgender women
Mesh:
Year: 2022 PMID: 36225140 PMCID: PMC9557018 DOI: 10.1002/jia2.25999
Source DB: PubMed Journal: J Int AIDS Soc ISSN: 1758-2652 Impact factor: 6.707
Measures for manifest variables included in latent class analysis models in the LITE Study of transgender women in the United States (N = 958)
| Variable | Measure description |
|---|---|
| HIV information from organizations | Based on answering “Yes” to any of the three following responses to the question “In the last 3 months, have you received any of the following services from a clinic, community organization or health facility (other than in this study)?”: “One‐on‐one conversation with an outreach worker, counsellor or prevention programme worker;” “Participated in an organized group session to discuss ways to prevent HIV infections;” or “Received HIV/STI prevention information (e.g. a flyer or info sheet)” |
| HIV knowledge | Based on answering the following two questions correctly: “What type of sex puts someone most at risk for HIV infection?” (answer = anal) and “Can someone get HIV from sharing a needle to inject hormones or silicone?” (answer = yes) |
| PrEP/PEP awareness | Based on answering “Yes” to either of the following questions: “Have you ever heard about PrEP (pre‐exposure prophylaxis) for the prevention of HIV infection in people who are HIV‐negative?” or “Have you heard of PEP for preventing HIV after someone has had possible contact with HIV (e.g. after unsafe sex or rape)?” |
| HIV test last year | Based on selecting any of the three response options to the question: “When was your most recent HIV test? If you're not sure, please give your best guess. If you are living with HIV, this refers to when you were first told that you have HIV.” Responses: “Less than 3 months ago,” “3–6 months ago,” or “7–11 months ago.” |
| PrEP use ever | Based on answering “Yes” to the question: “Have you ever taken PrEP (pre‐exposure prophylaxis) for the prevention of HIV infection?” |
| PEP use ever | Based on answering “Yes” to the question: “Have you ever taken PEP?” |
| Condomless sex | Based on answering “Yes” to the question: “In the last 12 months, have you ever had sex (anal or vaginal) without a condom?” |
| Receptive anal/vaginal sex | Based on answering “Yes” to any of the two sexual behaviours on the question: “Which type(s) of sex did you have with (casual partners, regular partners or sex work clients) in the last 3 months?” Behaviours: “Receptive anal sex (a partner put their penis in your anus or butt)” or “Receptive vaginal sex (a partner put their penis into your vagina).” |
| Insertive anal/vaginal sex | Based on answering “Yes” to any of the two sexual behaviours on the question: “Which type(s) of sex did you have with (casual partners, regular partners or sex work clients) in the last 3 months?” Behaviours: “Insertive anal sex (you put your penis in a partner's anus or butt)” or “Insertive vaginal sex (you put your penis in a partner's vagina.).” |
| Oral sex | Based on answering “Yes” to any of the four sexual behaviours on the question: “Which type(s) of sex did you have with (casual partners, regular partners or sex work clients) in the last 3 months?” Behaviours: “Receptive penile oral sex (a partner put their penis in your mouth),” “Insertive penile oral sex (you put your penis in a partner's mouth),” “Received oral‐vaginal sex (a partner put their mouth on your vagina),” or “Performed oral‐vaginal sex (you put your mouth on a partner's vagina).” |
Note. All manifest variables were recoded as binary (yes vs. no).
Abbreviations: PEP, post‐exposure prophylaxis; PrEP, pre‐exposure prophylaxis; STI, sexually transmitted infection.
Social demographics of sexually active transgender women in the LITE Study, Eastern and Southern United States (N = 958)
| Characteristics | Site‐based ( | Online ( | Total ( | |
|---|---|---|---|---|
| Age in years | 18–29 | 320 (56) | 231 (61) | 551 (58) |
| 30–39 | 147 (25) | 106 (28) | 253 (26) | |
| 40+ | 110 (19) | 44 (11) | 154 (16) | |
| Race/ethnicity | Non‐Hispanic White | 186 (32) | 287 (75) | 473 (49) |
| Non‐Hispanic Black | 122 (21) | 17 (4) | 139 (15) | |
| Hispanic White | 58 (10) | 12 (3) | 70 (7) | |
| Hispanic Black | 21 (4) | 1 (0.3) | 22 (2) | |
| Non‐Hispanic and more than one race or other | 83 (14) | 47 (12) | 130 (14) | |
| Hispanic and more than one race or other | 98 (17) | 15 (4) | 113 (12) | |
| Unknown | 9 (2) | 2 (0.5) | 11 (1) | |
| Education | <HS Diploma/GED | 212 (37) | 70 (18) | 282 (29) |
| ≥ Some college | 360 (62) | 309 (81) | 669 (70) | |
| Unknown | 5 (0.9) | 2 (0.5) | 7 (0.7) | |
| Income | Above FPL | 263 (46) | 255 (67) | 518 (54) |
| Below FPL | 223 (39) | 87 (23) | 310 (32) | |
| Unknown | 91 (16) | 39 (10) | 130 (14) | |
| Employment | Full‐time | 174 (30) | 181 (48) | 355 (37) |
| Part‐time | 139 (24) | 80 (21) | 219 (23) | |
| Not employed | 250 (43) | 108 (28) | 358 (37) | |
| Unknown | 14 (2) | 12 (3) | 26 (3) | |
| Insurance | Uninsured | 63 (11) | 37 (10) | 100 (10) |
| Public | 279 (48) | 90 (24) | 369 (39) | |
| Private | 192 (33) | 234 (61) | 426 (45) | |
| Unknown | 43 (7) | 20 (5) | 63 (7) | |
| Region | North | 296 (51) | 189 (50) | 485 (51) |
| Mid‐Atlantic | 151 (26) | 64 (17) | 215 (22) | |
| South | 130 (23) | 128 (33) | 258 (27) | |
Abbreviations: FPL, federal poverty line; GED, general educational development; HS, high school.
Figure 1Probability of endorsing each HIV awareness and prevention item among transgender women in the LITE Study, Eastern and Southern United States—site‐based (N = 577). Abbreviations: Orgs, organizations; PEP, post‐exposure prophylaxis; PrEP, pre‐exposure prophylaxis.
Figure 2Probability of endorsing each HIV awareness and prevention item among transgender women in the LITE Study, Eastern and Southern United States—online (N = 381). Abbreviations: Orgs, organizations; PEP, post‐exposure prophylaxis; PrEP, pre‐exposure prophylaxis.
Covariates table: demographics associated with class membership in site‐based and online cohorts among transgender women in the LITE Study, Eastern and Southern United States (March 2018–August 2020)
| Site‐based arm ( | Online arm ( | |||||
|---|---|---|---|---|---|---|
| Class | 2 | 3 | 4 | 2 | 3 | 4 |
| Limited strategies and insertive sex | Limited strategies and receptive sex | Multiple strategies and insertive/receptive sex | Limited strategies and insertive sex | Limited strategies and receptive sex | Multiple strategies and insertive/receptive sex | |
| Age in years (continuous) | 1.32 (0.90–1.93) | 1.36 (0.99–1.87) | 1.24 (0.93–1.66) |
|
| 0.73 (0.52–1.02) |
| POC (reference: White) |
| 1.11 (0.59–2.08) |
| 2.11 (0.52–8.50) | 3.79 (1.00–14.35) |
|
| ≥ Some college (reference: HS Diploma GED) |
| 1.16 (0.66–2.05) | 1.23 (0.72–2.10) |
| 1.49 (0.57–3.90) | 0.76 (0.26–2.17) |
| Income below federal poverty level (reference: above) |
|
| 0.80 (0.47–1.37) | 1.12 (0.31–4.03) | 2.16 (0.66–7.08) |
|
| Employment | ||||||
| Employed part‐time | 1.94 (0.86–4.38) | 1.76 (0.87–3.59) | 1.38 (0.69–2.75) | 1.68 (0.49–5.78) | 2.46 (0.76–7.99) | 1.06 (0.26–4.37) |
| Employed full‐time | 1.41 (0.69–2.90) | 1.09 (0.58–2.02) | 0.91 (0.50–1.64) |
|
|
|
| Insurance | ||||||
| Uninsured | 0.85 (0.26–2.77) | 1.65 (0.70–3.87) | 0.66 (0.26–1.69) | 0.63 (0.17–2.41) | 0.69 (0.20–2.45) | 0.66 (0.15–2.99) |
| Public |
| 0.69 (0.39–1.22) | 1.50 (0.87–2.57) | 1.02 (0.32–3.29) | 1.39 (0.46–4.22) |
|
| Private |
| 1.06 (0.57–1.95) | 0.68 (0.37–1.23) | 1.16 (0.44–3.01) | 0.59 (0.24–1.45) |
|
| Region | ||||||
| North | 1.71 (0.85–3.44) | 0.79 (0.45–1.40) | 0.99 (0.58–1.69) | 1.27 (0.53–3.02) | 1.11 (0.48–2.57) | 1.00 (0.38–2.61) |
| Mid‐Atlantic | 0.49 (0.20–1.17) | 0.91 (0.48–1.72) | 1.11 (0.62–2.00) | 0.72 (0.22–2.42) | 0.82 (0.26–2.59) | 2.19 (0.67–7.22) |
| South | 0.95 (0.40–2.22) | 1.51 (0.78–2.93) | 0.89 (0.45–1.72) | 0.92 (0.37–2.26) | 1.00 (0.42–2.38) | 0.51 (0.18–1.48) |
Note. Limited strategies and less sexually active is the reference group. Odds ratios are unadjusted. Boldface indicates statistically significant association—CI does not contain 1.0. Unknown responses were included in the modelling.
People of Colour (POC) include every race/ethnicity other than non‐Hispanic White versus non‐Hispanic White. Recoded because of the low prevalence of some racial groups. Unemployed did not yield robust estimates and was not included in this table.
Covariates table: gender‐affirming variables associated with class membership in site‐based and online arms among transgender women in the LITE Study, Eastern and Southern United States (March 2018–August 2020)
| Site‐based arm ( | Online arm ( | |||||
|---|---|---|---|---|---|---|
| 2 | 3 | 4 | 2 | 3 | 4 | |
| Class | Limited strategies and insertive sex | Limited strategies and receptive sex | Multiple strategies and insertive/receptive sex | Limited strategies and insertive sex | Limited strategies and receptive sex | Multiple strategies and insertive/receptive sex |
| Gender identity | ||||||
| Woman/female |
|
0.99 (0.56–1.76) |
0.85 (0.49–1.46) |
1.22 (0.39–3.82) |
1.58 (0.53–4.69) |
0.65 (0.16–2.61) |
| Transwoman/transfemale |
1.20 (0.60–2.38) |
0.85 (0.48–1.50) |
0.85 (0.50–1.46) |
1.16 (0.45–2.99) |
0.71 (0.29–1.73) |
1.11 (0.39–3.21) |
| Non‐binary or other gender diverse |
|
1.86 (0.58–5.98) |
2.64 (0.90–7.70) |
0.53 (0.13–2.12) |
1.04 (0.31–3.50) |
1.26 (0.32–4.91) |
|
Hormone therapy (past 3 months) |
|
1.10 (0.55–2.18) |
1.35 (0.69–2.66) |
1.27 (0.49–3.30) |
0.89 (0.36–2.20) |
2.26 (0.70–7.26) |
| Any gender‐affirming procedure |
1.44 (0.73–2.84) |
1.02 (0.58–1.80) |
1.54 (0.90–2.63) |
0.65 (0.27–1.57) |
0.67 (0.28–1.57) |
2.25 (0.84–6.01) |
| Trans‐specific HIV prevention info |
0.09 (0.01–1.03) |
1.20 (0.63–2.29) |
|
0.49 (0.11–2.09) |
0.97 (0.28–3.43) |
|
| Social support (high vs. low) |
|
1.75 (0.97–3.16) |
1.42 (0.81–2.49) |
|
1.20 (0.50–2.88) |
1.53 (0.57–4.12) |
Note. Limited strategies and less sexually active is the reference group. Odds ratios are unadjusted. Boldface indicates significant association—CI does not contain 1.0. “Prefer not to answer” and “Don't know” responses were included in the modelling.
Includes non‐binary, woman of trans experience, person of trans experience, two‐spirit and other identities.
Covariates table: HIV vulnerabilities associated with class membership in site‐based and online arms among transgender women in the LITE Study, Eastern and Southern United States (March 2018–August 2020)
| Site‐based arm ( | Online arm ( | |||||
|---|---|---|---|---|---|---|
| Class | 2 | 3 | 4 | 2 | 3 | 4 |
| Limited strategies and insertive sex | Limited strategies and receptive sex | Multiple strategies and insertive/receptive sex | Limited strategies and insertive sex | Limited strategies and receptive sex | Multiple strategies and insertive/receptive sex | |
| Positive STI test result (vs. negative‐lifetime) |
0.37 (0.10–1.42) |
1.70 (0.82–3.52) |
|
0.12 (0.00–11.33) |
1.34 (0.25–7.13) |
|
| Sex work (lifetime) |
0.47 (0.22–1.02) |
1.18 (0.67–2.10) |
|
0.72 (0.23–2.22) |
2.10 (0.77–5.78) |
|
|
Sex work (current) |
0.29 (0.02–3.97) |
|
|
0.46 (0.02–11.04) |
4.21 (0.49–36.18) |
|
| HIV risk | ||||||
| Med to high risk |
0.52 (0.18–1.51) |
1.67 (0.84–3.32) |
|
0.10 (0.00–6.77) |
2.39 (0.64–8.96) |
|
|
Low risk |
0.80 (0.40–1.59) |
1.05 (0.59–1.85) |
0.64 0.37–1.10) |
1.66 (0.61–4.52) |
1.68 (0.64–4.45) |
1.61 (0.54–4.84) |
|
No risk |
0.84 (0.34–2.09) |
0.65 (0.29–1.45) |
0.66 (0.31–1.37) |
0.88 (0.32–2.46) |
0.39 (0.13–1.17) |
0.42 (0.11–1.56) |
| No. of sex partners | ||||||
| One partner |
|
1.95 (0.98–3.85) |
0.88 (0.44–1.76) |
5.22 (2.00–13.61) |
0.55 (0.23–1.31) |
0.29 (0.10–0.88) |
| 2–4 partners |
2.04 (0.89–4.66) |
|
| – | – | – |
| Gender of sex partners | ||||||
| (12 months) | ||||||
|
Cisgender men |
|
|
| – | – | – |
|
Cisgender women |
|
0.73 (0.29–1.83) |
0.91 (0.44–1.92) |
1.75 (0.70–4.35) |
|
0.53 (0.20–1.40) |
|
TW/NB (MAB) |
2.22 (0.97–5.08) |
|
1.50 (0.74–3.05) |
3.31 (0.61–17.91) |
|
|
|
TM/NB (FAB) |
|
0.98 (0.40–2.42) |
0.91 (0.40–2.06) |
1.83 (0.64–5.26) |
0.87 (0.29–2.58) |
2.20 (0.71–6.86) |
Note. Limited strategies and less sexually active is the reference group. Odds ratios are unadjusted. Boldface indicates significant association—CI does not contain 1.0. Positive STI test—last 3 months, zero partners, 2–4 partners (online arm only), 5+ partners and cisgender men (online arm only) did not yield robust estimates and were not included in this table. “Prefer not to answer” responses and never tested category were also included in the model when applicable. HIV risk is missing data from one participant.
Unstable confidence intervals should be interpreted with caution.
Abbreviations: FAB, female assigned at birth; MAB, male assigned at birth; NB, non‐binary; STI, sexually transmitted infection; TM, transgender men; TW, transgender women.